Compare Mutual Funds

Pros
5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Among most bought funds within the category.

Among most bought funds within the category.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
1/8
8/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

13 Years 10 Months

13 Years 10 Months

Fund AUM

₹5400 Cr

₹9279 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1.02%

1%

Exit Load

0.5%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

36

38

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(12.72%)
  2. Divi's Laboratories Ltd(7.46%)
  3. Acutaas Chemicals Ltd(5.17%)
  4. Cipla Ltd(5.07%)
  5. Apollo Hospitals Enterprise Ltd(4.98%)
  1. Sun Pharmaceuticals Industries Ltd(13.31%)
  2. Lupin Ltd(7.25%)
  3. Divi's Laboratories Ltd(6.52%)
  4. Cipla Ltd(6.03%)
  5. Apollo Hospitals Enterprise Ltd(5.3%)
No of Sectors

3

1

Top 3 Sectors
  1. Health(92.41%)
  2. Basic Materials(7.59%)
  3. Government(2.09%)

Health

(100%)

Equity %

98.29%

97.32%

Debt %

0.05%

-

P/E

48.73

39.56

P/B

6.74

5.84

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

0.65%

-0.13%

3-Month Return

12.85%

7.73%

6-Month Return

23.06%

13.29%

1-Year Return

21.26%

11.67%

3-Year Return

24.72%

19.37%

5-Year Return

18.34%

13.55%

Sharpe

1.21

0.89

Alpha

3.34

-1.21

Beta

0.86

0.88

Standard Deviation

14.38

14.77

Information Ratio

0.41

-0.88

Description

SBI Healthcare Opportunities Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Tanmaya Desai

Sailesh Raj Bhan, Kinjal Desai, Amber Singhania

Most Popular Comparisons